The Lyme pandemic exposed by Covid is a compelling topic for medical care providers as long haulers continue to grow. Bruce Patterson of Incelldx joined us to present new data on Lyme and the use of Long Hauler Index (LHI) and Severity Score (SS) to diagnose and monitor Long COVID. Most importantly, this combination of algorithms has allowed the diagnosis of Chronic Lyme disease.  In this video, he describes the Lyme pandemic that covid uncovered, and how they are using machine learning to understand better what patients are going through.
 
New algorithms were discussed in his presentation with easy interpretation of the IncellKINE 14-plex cytokine panel for use by all physicians. A new report format will be shown that gives the probability of LC, Lyme, ME-CFS, or acute COVID during the initial visit to the Chronic COVID Treatment Center (CCTC). He also announced that all CCTC tests can be ordered by ANY practitioner now including MD, DO, NP, and PA.  You can find him at www.covidlonghaulers.com.

Kristina has been on Dr. Patterson's protocol beginning in September of 2021, and has seen great success in lowering multiple elevated markers!  We are very grateful for doctors like Dr. Patterson that conducts research without subjective bias, to truly put patients' well being first.  He will be conducting a clinical trial for the Lyme community and look forward to sharing his updates as it comes out.

You will need a doctor to prescribe your protocol recommended by Dr. Patterson.  His office will help you find one if you need it, direct any questions to his nurses and office that you may have.  Texas Lyme Alliance, Kristina Bauer or any of our associates do not recommend using this video as medical advice.  You can send this video to your doctor so they can learn about this application. 

Thank you Dr. Patterson, incellDX, and all our sponsors for supporting our "Chronic Inflammation Event May 2023 event".  If you found this helpful, subscribe to this channel, like this video and support our work by sharing it with your healthcare practitioners, health groups, show in your support groups, and with your family.  Thank you for watching and good luck!

#Lyme #covid19  #Lymeresearch #nopatientleftbehind

With 477,000 newly infected Lyme patients every year, and 40% of those are pediatric, Lyme patients need a working diagnostic and effective treatment.  New developments out of Duke University, carried forward from the late Oncologist and Lyme patient, Dr. Neil Spector, shows promise to solve every Lyme patients nightmare for accurate testing and an effective treatment.  Inspired by research that targets cancer tumors, these new findings in Lyme could also lead to novel R&D strategies for other diseases.

PORTOLA VALLEY, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced the development of a potential new drug, HS-291, that targets and destroys Borrelia burgdorferi, the bacterium that causes Lyme disease. Published in the peer-reviewed journal Cell Chemical Biology, this laboratory study represents a novel paradigm shift for anti-microbial treatment research as it is the first to target and inhibit Borrelia burgdorferi HtpG (high temperature protein G), a specific type of enzyme within the bacteria that causes Lyme disease— a condition affecting nearly 500,000 new patients annually. The research was conducted at Duke University School of Medicine, with collaboration from University of North Carolina, Tulane University, and Stanford University, and HS-291 is currently in preclinical stage testing at UC Davis.

“As Lyme disease is currently treated with broad spectrum antibiotics and there are no targeted treatments, we are particularly excited about this discovery, and hopeful that our novel Lyme disease therapeutic HS-291 will specifically destroy the Lyme bacterium without off-target effects or antibiotic resistance,” said Timothy Haystead, PhD, professor of Pharmacology and Cancer Biology, Duke University School of Medicine, Bay Area Lyme Foundation grantee, and co-lead author. “This research has been an incredible opportunity to leverage knowledge from oncology to Lyme disease in order to design an investigational therapeutic that could one day benefit hundreds of thousands of patients with Lyme.”

This new discovery has implications beyond Lyme disease as it demonstrates that using the drug HS-291 to deliver cellular toxins to HtpG, a type of non-essential enzyme that assists the folding or unfolding of large and complex proteins, greatly expands what can be considered druggable within any pathogen and opens a whole new area of infectious disease research.

This work will require around a $10mm total investment to bring to the public.  We are bringing this presentation to you today from Dr. Tim Haystead to show you the power of this work and why it's important to join us to support ensuring Dr Spector's mission is successful through donations.  Every amount helps, so please donate at www.TXLymeAlliance.org/donate and subscribe to our channel to support our efforts to open access to care for Lyme patients. SHARE this to help us find solutions for those suffering from Lyme disease.

#LymeDisease #Dukeuniversity #NeilSpector #Lymetreatment #Lymeresearch

Dr. Dan Kinderlerer discusses how he treats a lot of patient with THC and CBD to help lesson Lyme symptoms.  These symptoms include lowering neuro inflammation, less night terrors, and lower pain and anxiety with great success.  Every human has an endocannabinoid system only for processing marijuana, and nothing else as far as we know to date.  Many studies validate it's use in MS, for pain, and many other benefits, one study is: https://www.ncbi.nlm.nih.gov/books/NBK425767/.

Please excuse the camera exposure as my old equipment was going out but I didn't want to not share the great information, I adjusted it as much as I could.  *Not intended as medical advice.  Medical THC/CBD is legal in Texas now and in a lot of states.  Search your area for details, but in Texas a lot of people use Texas Originals: https://texasoriginal.com/.

#neuroscience #thc #cbd #dankinderleher #lymedisease #endocannabinoidsystem